The estimated Net Worth of Mark Mcdade is at least $21.6 Million dollars as of 12 June 2019. Mark Mcdade owns over 3,000 units of PDL Biopharma Inc stock worth over $21,636,000 and over the last 21 years Mark sold PDLI stock worth over $0.
Mark has made over 42 trades of the PDL Biopharma Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Mark exercised 3,000 units of PDLI stock worth $10,818,000 on 12 June 2019.
The largest trade Mark's ever made was exercising 20,000 units of PDL Biopharma Inc stock on 8 January 2007 worth over $166,000. On average, Mark trades about 6,130 units every 77 days since 2003. As of 12 June 2019 Mark still owns at least 6,000 units of PDL Biopharma Inc stock.
You can see the complete history of Mark Mcdade stock trades at the bottom of the page.
Mark's mailing address filed with the SEC is C/O AIMMUNE THERAPEUTICS, INC., 8000 MARINA BOULEVARD, SUITE 300, BRISBANE, CA, 94005-1884.
Over the last 22 years, insiders at PDL Biopharma Inc have traded over $45,966,964 worth of PDL Biopharma Inc stock and bought 12,693,393 units worth $32,804,545 . The most active insiders traders include Point Capital L.P.O'shea Ro..., Faheem Hasnain, and Laurence Jay Korn. On average, PDL Biopharma Inc executives and independent directors trade stock every 24 days with the average trade being worth of $245,074,578. The most recent stock trade was executed by Point Capital L.P.O'shea Ro... on 1 February 2021, trading 187,061 units of PDLI stock currently worth $383,475.
PDL Biopharma Inc executives and other stock owners filed with the SEC include: